CAV1 and hepatocellular carcinoma: In this study, we demonstrate for the first time that multiple TKI-resistant HCC cell lines, which recapitulate the molecular features of in vivo resistance, share a common mechanism of pan-TKI resistance driven via the CAV1 signalling pathway.